Recent News

• 09.09.2025 - H.C. Wainwright 27 Annual Global Investment Conference
• 09.09.2025 - H.C. Wainwright 27 Annual Global Investment Conference
• 09.04.2025 - Cantor Global Healthcare Conference
• 09.04.2025 - Cantor Global Healthcare Conference
• 09.02.2025 - Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 09.02.2025 - Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 09.02.2025 - Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 08.27.2025 - Protara Therapeutics to Participate in Upcoming Investor Conferences
• 08.27.2025 - Protara Therapeutics to Participate in Upcoming Investor Conferences
• 08.11.2025 - Protara Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update

Recent Filings

• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.11.2025 - 8-K Current report
• 08.11.2025 - EX-99.1 EX-99.1
• 08.11.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 08.11.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]